EDESA BIOTECH, INC. Accounts and Other Receivables, Net, Current
EDESA BIOTECH, INC. (EDSA) had Accounts and Other Receivables, Net, Current of $228.05 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsAndOtherReceivablesNetCurrent · last filed 2026-08-13
- 2026-06-30: Accounts and Other Receivables, Net, Current $228.05K.
- 2026-03-31: Accounts and Other Receivables, Net, Current $216.47K.
- 2025-12-31: Accounts and Other Receivables, Net, Current $431.32K.
- 2025-09-30: Accounts and Other Receivables, Net, Current $642.87K.
| Period end | Accounts and Other Receivables, Net, Current |
|---|---|
| 2026-06-30 | $228.05K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $216.47K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $431.32K 10-Q · filed 2026-02-13 |
| 2025-09-30 | $642.87K 10-Q · filed 2026-08-13 |
| 2025-06-30 | $286.74K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $382.44K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $350.64K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $270.91K 10-K · filed 2025-12-12 |
| 2024-06-30 | $551.06K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $1.11M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $743.57K 10-Q · filed 2024-02-09 |
| 2023-09-30 | $626.54K 10-K · filed 2024-12-13 |
| 2023-06-30 | $42.87K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $50.23K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $125.48K 10-Q · filed 2023-02-10 |
| 2022-09-30 | $1.26M 10-K · filed 2023-12-15 |
| 2022-06-30 | $1.40M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $1.25M 10-Q · filed 2022-05-13 |
| 2021-09-30 | $3.30M 10-K · filed 2022-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |